Literatur
- 03
Hurwitz H .
Rehrenbacher L .
Novotmy W .
et al .
Bevacizumab plus irinotecan, fluorouracil, and leucoverin for metastatic colorectal
cancer.
N Engl J Med.
2004;
350
2335-2342
- 04 Kozloff M . Cohn A . Christiansen N . et al . Safety of bevacizumab (BV) among
patients (pts) receiving first-line chemotherapy for metastatic colorectal cancer:
updated results from a large observational study in the U.S. (BRITE). GI ASCO 2006;
abstract 247.
08 Eastern Cooperative Oncology Group
09 Bevacixumab Regimes Investigation of Treatment Effects and Safety
